简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2025-03-14 11:29 NordicTrack Celebrates 50 Years of Innovation With Debut of Its New Ultra 1 Luxury Treadmill
2025-03-14 10:56 Myrobalan Therapeutics Awarded a Grant from the National Multiple Sclerosis Society to Advance Development of MRO-002 in Multiple Sclerosis
2025-03-12 10:42 Estée Lauder Announces Dr. Matthew Walker as Brand’s First-Ever Global Sleep Science Advisor
2025-03-12 10:13 Data Zoo Named a Leader in Liminal’s Link Index for Age Verification
2025-03-11 16:40 Pharmaceutical Industry Issues Call for Collective Action to Address the Rising Global Burden of Chronic Disease
2025-03-07 16:31 Kenvue Announces Three New Appointments to Board of Directors
2025-03-07 12:07 Novotech Releases Hepatitis B Global Clinical Trial Landscape Report 2025
2025-03-06 14:05 Galderma Delivers 2024 Record Net Sales of 4.410 Billion USD, up 9.3% Year-on-Year at Constant Currency1, and Record Core EBITDA of 1.031 Billion USD, While Preparing to Accelerate Its Growth Trajectory Into 2025 and Beyond
2025-03-06 10:52 InterSystems Unveils IntelliCare: A Next-Generation, AI-Powered Electronic Health Record
2025-03-06 10:34 Aster Guardians Global Nursing Award 2025 Worth $250,000 Extends Nomination Deadline to 9th March
2025-03-05 10:25 Parse Biosciences Advances Plans to Release Single Cell Chromatin Accessibility Products
2025-03-04 15:54 Celltrion Receives EC Approval for Avtozma® (CT-P47), a Biosimilar to RoActemra® (tocilizumab)
2025-03-04 09:18 Protagonist and Takeda Announce Positive Topline Results from Phase 3 VERIFY Study of Rusfertide in Patients with Polycythemia Vera
2025-03-03 16:11 BeiGene Announces Fourth Quarter and Full Year 2024 Financial Results and Business Updates
2025-03-03 14:05 AAD 2025: Galderma to Present Extensive Updates From Across Its Dermatology Portfolio, Demonstrating Its Category Leadership and Strong Momentum
2025-03-03 10:49 New Bipolar Disorder Study Shows that a Ketogenic Diet Leads to Mental and Physical Health Benefits
2025-03-03 10:21 Astria Therapeutics Initiates ALPHA-ORBIT Phase 3 Pivotal Trial of Navenibart in Hereditary Angioedema
2025-03-03 10:12 SINOVAC Announces New Board Pursuant to Privy Council Judgment and Order
2025-02-28 17:55 Cynosure Lutronic and Amico Aesthetics Join Forces by Signing a Strategic Distribution Agreement for the Middle East
2025-02-28 09:27 The Estée Lauder Companies Partners with Serpin Pharma, Inc to Develop Breakthrough Skin Care Ingredients to Advance Longevity

Business Wire Weibo

Press Releases

Latest Releases